197 related articles for article (PubMed ID: 37426314)
1. Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017.
Zalin-Miller A; Jose S; Knott C; Paley L; Tataru D; Morement H; Toledano MB; Khan SA
World J Gastroenterol; 2023 Jun; 29(24):3825-3842. PubMed ID: 37426314
[TBL] [Abstract][Full Text] [Related]
2. Cancer diagnoses after emergency GP referral or A&E attendance in England: determinants and time trends in Routes to Diagnosis data, 2006-2015.
Herbert A; Abel GA; Winters S; McPhail S; Elliss-Brookes L; Lyratzopoulos G
Br J Gen Pract; 2019 Oct; 69(687):e724-e730. PubMed ID: 31455644
[TBL] [Abstract][Full Text] [Related]
3. Cohort study to assess geographical variation in cholangiocarcinoma treatment in England.
Jose S; Zalin-Miller A; Knott C; Paley L; Tataru D; Morement H; Toledano MB; Khan SA
World J Gastrointest Oncol; 2023 Dec; 15(12):2077-2092. PubMed ID: 38173436
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of cholangiocarcinoma.
Bergquist A; von Seth E
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
[TBL] [Abstract][Full Text] [Related]
5. Inter general practice variability in use of referral guidelines for colorectal cancer.
John SK; Jones OM; Horseman N; Thomas P; Howell RD; Fozard JB
Colorectal Dis; 2007 Oct; 9(8):731-5. PubMed ID: 17854292
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinoma across England: Temporal changes in incidence, survival and routes to diagnosis by region and level of socioeconomic deprivation.
Tataru D; Khan SA; Hill R; Morement H; Wong K; Paley L; Toledano MB
JHEP Rep; 2024 Mar; 6(3):100983. PubMed ID: 38357420
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma.
Sarcognato S; Sacchi D; Fassan M; Fabris L; Cadamuro M; Zanus G; Cataldo I; Capelli P; Baciorri F; Cacciatore M; Guido M
Pathologica; 2021 Jun; 113(3):158-169. PubMed ID: 34294934
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis.
Newsome JR; Venkatramani R; Heczey A; Danysh HE; Fishman DS; Miloh T
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):e12-e18. PubMed ID: 28937543
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
[TBL] [Abstract][Full Text] [Related]
10. Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality.
Burton A; Wilburn J; Driver RJ; Wallace D; McPhail S; Cross TJS; Rowe IA; Marshall A
Br J Cancer; 2024 Jun; 130(10):1697-1708. PubMed ID: 38499728
[TBL] [Abstract][Full Text] [Related]
11. Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications.
Lin CC; Lin PY; Chen YL
World J Gastroenterol; 2013 Jan; 19(3):375-80. PubMed ID: 23372360
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Plentz RR; Malek NP
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
[TBL] [Abstract][Full Text] [Related]
13. Geographical access to GPs and modes of cancer diagnosis in England: a cross-sectional study.
Murage P; Bachmann MO; Crawford SM; McPhail S; Jones A
Fam Pract; 2019 May; 36(3):284-290. PubMed ID: 30452584
[TBL] [Abstract][Full Text] [Related]
14. The effect of the 2-week wait referral system on the detection of and mortality from colorectal cancer: protocol of a systematic review and meta-analysis.
Mozdiak E; Tsertsvadze A; McFarlane M; Widlak M; Tabuso M; Dunlop A; Arasaradnam R
Syst Rev; 2016 Oct; 5(1):182. PubMed ID: 27784334
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer outcomes determined by mode of presentation: analysis of population data in England between 2010 and 2014.
Franklyn J; Lomax J; Labib P; Baker A; Hosking J; Moran B; Smolarek S
Tech Coloproctol; 2022 May; 26(5):363-372. PubMed ID: 35084620
[TBL] [Abstract][Full Text] [Related]
16. Routes to diagnosis for sarcoma - Describing the sarcoma patient journey.
Gerrand C; Francis M; Dennis N; Charman J; Lawrence G; Evans T; Grimer R
Eur J Surg Oncol; 2015 Oct; 41(10):1393-9. PubMed ID: 26278018
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma: risk factors and clinical presentation.
Gatto M; Alvaro D
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):363-7. PubMed ID: 20496549
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
19. Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013.
Di Girolamo C; Walters S; Gildea C; Benitez Majano S; Rachet B; Morris M
PLoS One; 2018; 13(8):e0201288. PubMed ID: 30133466
[TBL] [Abstract][Full Text] [Related]
20. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB
J Hepatol; 2012 Apr; 56(4):848-54. PubMed ID: 22173164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
